I just want to make sure, Mr. Garneau. Are you aware that this amendment would restrict the list of drugs available back to 2004, even Health Canada drugs that had no objection back in 2004, including Moxifloxacin, which was lobbied by Bayer to stay off the list. My concern with this amendment is that WTO and TRIPS and the Doha didn't have a restricted requirement of drugs on the list.
We've already seen some active campaigning by the pharmaceutical industry. It actually made the headlines of the Ottawa Citizen back in 2004 because it defeated the whole purpose of lists. I'd just like to see if there are any reassurances or any changes because we would be restricting the list to what currently exists and the process for adding a drug is rather cumbersome.